Hepatoselüler karsinomların saptanmasında ve karakterizasyonunda trifazik spiral bilgisayarlı tomografinin tanı değeri

Amaç: Hepatoselüler karsinomların (HK) saptanmasında ve karakterizasyonunda, trifazik spiral Bilgisayarlı Tomografinin (BT) tanı değerini araştırmak. Gereç ve yöntem: 31 HK’lı hasta (18 erkek, 13 kadın, 15 -76 yaş aralığında, ortalama 60.3 ± 11.3) ile karaciğerinde fokal lezyonu olan 7 hasta trifazik spiral BT protokolü ile incelendi. 150 ml kontrast madde, 3 ml/s hız, unifazik uygulama, hepatik arteriyel faz (HAF) için 20-40 s gecikme zamanı, portal venöz faz (PVF) için 60-90 s gecikme zamanı, geç faz (GF) için 3-8 dk gecikme zamanı ile tüm hastalarda, HAF’da iyi bir vasküler kontrastlanma, PVF’da yeterince parankimal kontrastlanma, GF’da da ekstravasküler boşlukta kontrastlanma sağlandı. Bulgular: 31 HK ile birlikte, 3 kist, 3 hemanjom, 1 fokal nodüler hiperplazi saptandı. HK olguları HAF’da % 58 (n=18) hiperattenuasyon, % 32 (n=10) hipoattenuasyon, % 10 (n=3) izoattenuasyon, PVF’da % 54 (n=17) hipoattenuasyon, % 32 (n=10) hiperattenuasyon, % 14 (n=4) izoattenuasyon, GF’da ise % 74 (n=23) hipoattenuasyon, % 19 (n=6) hiperattenuasyon ve % 7 (n=2) izoattenuasyon gösterdi. (HAF+ PVF+GF)’da (trifazik) incelemenin sensitivitesi (% 90.3), sadece (HAF+ PVF)’da (dual faz) incelemenin sensitivitesinden (% 88.7) yüksek olarak saptandı. Sonuç: Trifazik spiral BT, HK ve diğer KC’deki fokal lezyonların saptanmasında ve karakterizasyonunda standart BT tekniği olarak hızla kabul görmüştür. İleride otomatik bilgisayar programları ile kullanılan parametreler optimize edilerek daha iyi sonuçlar elde edilebilecektir.

The value of triphasic computed tomography in the detection and characterization of hepatocellular carcinomas

Objective: To evaluate the value of triphasic computed tomography (CT) in the detection and characterization of hepatocellular carcinomas (HCC). Materials and methods: Thirty-one HCC cases (18 male, 13 female, range 15-76 years, mean 60.3 ± 11.3) and 7 cases with focal liver lesions evaluated with triphasic spiral CT. We got optimum vascular contrast in hepatic arterial phase (HAP), paranchymal contrast in portal venous phase (PVP), and extravascular space contrast in late phase (LP) with 150 ml of non-ionic contrast material containing 300 mg/ml iodine, and 3 ml/sec monophasic injection rate, 20-40 second delay time for HAP, 60-90 second delay time for PVP and 3-8 minutes delay time for LP respectively. Results: With 31 HCC patients we detected 3 cysts, 3 hemangiomas and focal nodular hiperplasia. HCCs were hyperattenuated 58% (n=18), hypoattenuated 32% (n=10), and isoattenuated 10% (n=3) in HAP; hypoattenuated 54% (n=17), hyperattenuated 32% (n=10), isoattenuated 14% (n=4) in PVP; hypoattenuated 74% (n=23), hyperattenuated 19% (n=6), isoattenuated 7% (n=2) in LP. Sensitivity of HAP+PVP+LP (triphasic) CT (90.3%) was significantly higher than that of PVP+LP (dual phase) CT (88.7%). Conclusion: Triphasic spiral CT accepted as a standart CT technique for detection and characterization of HCC and focal liver lesions. We realized that we could get good results by automatic computer programs optimization in future.

___

  • 1. Craig JR, Peters RL, Edmonson HA. Tumors of the liver and intrahepatic bile ducts (second series). Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology, 1989.
  • 2. Dean PB, Violante MR, Mahoney JA. Hepatic CT contrast enhancement: Effect of dose, duration of infusion, and time elapsed following infusion. İnvest Radiol 1980; 15:158-61.
  • 3. Foley WD. Dynamic hepatic CT. Radiology 1989; 170:617- 22.
  • 4. Paushter DM, Zeman RK, Scheibler ML, Coyke PL, Jaffe MH, Clark JR. CT evaluation of suspected hepatic metastases: comparison of techniques for IV contrast enhancement. AJR 1989; 152:267-71.
  • 5. Baron RL, Dodd GD III, Holbert BL, Oliver JH III, Carr B. Helical biphasic contrast CT in evaluation of hepatocellular carsinoma. Radiology 1994; 193(P):435.
  • 6. Karahan OI, Yikilmaz A, Isin S, Orhan S. Characterization of hepatocellular carcinomas with triphasic CT and correlation with histopathologic findings. Acta Radiol 2003;44:566-71.
  • 7. Miller FH, Butler RS, Hoff FL, Fitzgerald SW, Nemcek AA Jr, Gore RM. Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. AJR Am J Roentgenol 1998;171:643-9.
  • 8. van Leeuwen MS, Noordzij J, Feldberg MA, Hennipman AH, Doornewaard H Focal liver lesions: characterization with triphasic spiral CT. Radiology 1996;201:327-36.
  • 9. Lim JH, Choi D, Kim SH, Lee SJ, Lee WS, Lim HK, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002;179:67-73.
  • 10. Stoker J, Romijn MG, de Man RA, Brouwer JT, Weverling GJ, van Muiswinkel JM, et al. Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma. Gut 2002;51:105-7.
  • 11. Güney D. Karaciğer kitlelerinde bilgisayarlı tomografi. TRD yayınları 23. Radyoloji Kongresi Bilgisayarlı Tomografi kitabı Ankara 2002;122-7
  • 12. Ritchings RJT, Pullan BR, Lucas SB, Fawcitt RA, Best SS, Isherwood J, et al. An analysis of the spatial distribution of attenuation values in computed tomographic scans of liver and spleen. J Comput Assist Tomogr 1979;3:36-9.
  • 13. Burgener FA, Hamlin DJ. Contrast enhancement in abdominal CT: Bolus vs. infusion. AJR 1981;137:351-8.
  • 14. Foley WD. Dynamic hepatic CT. Radiology 1989;170;617-22.
  • 15. Bismuth H. Surgical anatomy and anatomical surgery of the liver.World J Surg 1982; 6:3-9.
  • 16. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994;190:49-52.
  • 17. Freeny PC, Marks WM. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT Radiology 1986; 160:613-8
  • 18. Berland LL, Lee JY. Comparision of contrast media injection rates and volumes for hepatic dynamic incremented computed tomography. Invest Radiol 1988;23:918-22.
  • 19. Berland LL. Slip-ring and conventional dynamic hepatic CT: contrast material and timing considerations. Radiology 1995;195:1-8.
  • 20. Bluemke DA, Fishman EK. Spiral CT of the liver. AJR 1993;160:787-92.
  • 21. Bluemke DA, Urban BA, Fishman EK. Spiral CT of the liver: current applications. Semin Ultrasound CT MR 1994; 15:107- 21.
  • 22. Belton RL, Van Zandt TF. Congenital absence of the left lobe the liver: A radiographic diagnosis. Radiology 1983; 147:184- 7.
  • 23. Foley WD, Hoffmann RG, Quiroz FA, Kahn CE, Perret RS. Hepatic helical CT: Contrast material injection protocol. Radiology 1994;192:367-71.
  • 24. Freeny PC, Baron RL, Teefey SA. Hepatocellular carsinoma: reduced frequency of typical findings with dynamic contrastenhanced CT in a non-Asian population. Radiology 1992;182:143-8.
  • 25. Friedman AC, Lichtenstein JE, Goodman Z, Fishman EK, Siegelman SS, Dachman AH. Fibrolamellar hepatocellular carsinoma. Radiology 1985;157:583-7.
  • 26. Ichikawa T, Ohtomo K, Takhashi S. Hepatocellular carsinoma: detection with double-phase helical CT during arterial portography. Radiology 1996;198:284-7.
  • 27. Brink JA, Heiken JP, Wang G, McEnery KW, Schlueter FS, Vannier MW. Helical CT: Principles and technical considerations. Radiographics 1994,14:887-93.
  • 28. Brink JA. Technical aspects of helical (spiral) CT. Radiol Clin North Am 1995;33:824-41.
  • 29. Bonaldi VM, Bret PM, Reinhold C, Atri M. Helical CT of the liver: Value of an early hepatic arterial phase. Radiology 1995;197:357-63.